🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 72 of 99

  1. REGN1193

    Regeneron UK Limited

    Diabetes Mellitus, Type 2

    phase 1 small molecule terminated

    1 trial

  2. REGN1193

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. REGN13335

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  4. REGN1400

    Regeneron UK Limited

    Cancer

    phase 1 small molecule completed

    1 trial

  5. REGN14284

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  6. REGN1500

    Regeneron UK Limited

    Metabolic Disorders

    phase 1 small molecule completed

    1 trial

  7. REGN1500

    Regeneron UK Limited

    Hypertriglyceridemia

    phase 1 small molecule completed

    1 trial

  8. REGN15160 (IV)

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  9. REGN17092

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. REGN1908-1909

    Regeneron UK Limited

    Allergy

    phase 1 small molecule completed

    2 trials

  11. REGN2009

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  12. REGN20423

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  13. REGN20934

    Regeneron UK Limited

    Overweight or Obesity

    phase 1 small molecule active

    1 trial

  14. REGN2176-3

    Regeneron UK Limited

    Neovascular Wet Age-related Macular Degeneration (AMD)

    phase 1 small molecule completed

    1 trial

  15. REGN22044

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  16. REGN2222

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  17. REGN2222(SAR438584)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  18. REGN2477

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. REGN2810

    Regeneron UK Limited

    Melanoma

    phase 1 small molecule completed

    1 trial

  20. REGN2810

    Regeneron UK Limited

    Advanced Malignancies

    phase 1 small molecule terminated

    1 trial

  21. REGN2810

    Regeneron UK Limited

    Recurrent Squamous Cell Carcinoma of Head

    phase 1 small molecule completed

    1 trial

  22. REGN3470-3471-3479

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. REGN3500

    Regeneron UK Limited

    Asthma

    phase 1 small molecule completed

    1 trial

  24. REGN3500

    Regeneron UK Limited

    Asthma, Allergic

    phase 1 small molecule completed

    1 trial

  25. REGN3500

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  26. REGN3767

    Regeneron UK Limited

    Malignancies

    phase 1 small molecule completed

    1 trial

  27. REGN3918

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  28. REGN421(SAR153192)

    Regeneron UK Limited

    Advanced Solid Malignancies

    phase 1 small molecule completed

    1 trial

  29. REGN4461

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. REGN4659

    Regeneron UK Limited

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule terminated

    1 trial

  31. REGN475 (SAR164877)

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  32. REGN5069

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  33. REGN5093-M114

    Regeneron UK Limited

    Advanced NSCLC

    phase 1 small molecule terminated

    1 trial

  34. REGN5381

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  35. REGN5678

    Regeneron UK Limited

    Prostate Cancer

    phase 1 small molecule active

    1 trial

  36. REGN5713-5714-5715

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  37. REGN6490

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule terminated

    2 trials

  38. REGN6569

    Regeneron UK Limited

    Squamous Cell Carcinoma of Head and Neck

    phase 1 small molecule terminated

    1 trial

  39. REGN668

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  40. REGN668

    Regeneron UK Limited

    Dermatitis

    phase 1 mab completed

    1 trial

  41. REGN668: Injection Rate 1

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  42. REGN7257

    Regeneron UK Limited

    Severe Aplastic Anemia (SAA)

    phase 1 small molecule terminated

    1 trial

  43. REGN727

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  44. REGN727

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  45. REGN727(SAR236553)

    Regeneron UK Limited

    Hypercholesterolemia

    phase 1 small molecule completed

    1 trial

  46. REGN728

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  47. REGN7508 (IV)

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  48. REGN7544

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.